Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review

References

• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2019 Available from: https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.7-FINAL-14Nov2018-WMS.pdf. Accessed 311, 2019.
   Google Scholar
• AdeloyeD, ChuaS, LeeC, et al. Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health. 2015;5(2):020415. doi:10.7189/jogh.05.02041526755942
   PubMed Web of Science ®Google Scholar
• GuarascioAJ, RaySM, FinchCK, SelfTH. The clinical and economic burden of chronic obstructive pulmonary disease in the USA. Clinicoecon Outcomes Res. 2013;5:235–245. doi:10.2147/CEOR.S3432123818799
   PubMedGoogle Scholar
• LøkkeA, HilbergO, TønnesenP, IbsenR, KjellbergJ, JennumP. Direct and indirect economic and health consequences of COPD in Denmark: a national register-based study: 1998–2010. BMJ Open. 2014;4(1):e004069. doi:10.1136/bmjopen-2013-004069
   PubMed Web of Science ®Google Scholar
• WackerME, JörresRA, KarchA, et al. Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities. BMC Pulm Med. 2016;16(1):70.27160582
   PubMed Web of Science ®Google Scholar
• MoherD, LiberatiA, TetzlaffJ, AltmanDG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.100009719621072
   PubMed Web of Science ®Google Scholar
• KolevaD, MotterliniN, BanfiP, GarattiniL. Healthcare costs of COPD in Italian referral centres: a prospective study. Respir Med. 2007;101(11):2312–2320. doi:10.1016/j.rmed.2007.06.02017681461
   PubMed Web of Science ®Google Scholar
• MerinopoulouE, Raluy-CalladoM, RamagopalanS, MacLachlanS, KhalidJM. COPD exacerbations by disease severity in England. Int J Chron Obstruct Pulmon Dis. 2016;11:697–709. doi:10.2147/COPD.S10025027099486
   PubMed Web of Science ®Google Scholar
• MullerovaH, HanMK, BaxterR, GOLDDK. 2013 COPD classification: a comparison with GOLD 2011 and COPD outcomes in the UK Clinical Practice Research Datalink (CPRD) COPD cohort. Am J Respir Crit Care Med. 2014;189:A5965. doi:10.1164/rccm.201306-1150OC
   Web of Science ®Google Scholar
• PunekarYS, WurstK, ShuklaA. Resource use and costs up to two years post diagnosis among newly diagnosed COPD patients in the UK primary care setting: a retrospective cohort study. COPD. 2015;12(3):267–275. doi:10.3109/15412555.2014.93395325093809
   PubMedGoogle Scholar
• ThomasM, RadwanA, StonhamC, MarshallS. COPD exacerbation frequency, pharmacotherapy and resource use: an observational study in UK primary care. COPD. 2014;11(3):300–309. doi:10.3109/15412555.2013.84167124152210
   PubMedGoogle Scholar
• Bustamante-FermoselA, De Miguel-yanesJM, Duffort-FalcóM, MunozJ. Mortality-related factors after hospitalization for acute exacerbation of chronic obstructive pulmonary disease: the burden of clinical features. Am J Emerg Med. 2007;25(5):515–522. doi:10.1016/j.ajem.2006.09.01417543654
   PubMed Web of Science ®Google Scholar
• ValidoA, Gomez-BasteroA, AlmadanaV, LuqueE, MontemayorT. Clinical and functional differences, exercise capacity and physical activity among frequent and not frequent exacerbators in COPD patients. Eur Respir J. 2014;44(Suppl 58):P4883. doi:10.1183/09031936.00003814
   Web of Science ®Google Scholar
• MartínA, Rodríguez-González MoroJM, IzquierdoJL, GobarttE, de LucasP. Health-related quality of life in outpatients with COPD in daily practice: the VICE Spanish Study. Int J Chron Obstruct Pulmon Dis. 2008;3(4):683–692. doi:10.2147/COPD.S479119283915
   PubMedGoogle Scholar
• PunekarYS, LandisSH, BonarK, LeH. Health care utilisation and costs among COPD patients newly prescribed maintenance therapy in the United Kingdom (UK). Thorax. 2015b;70:A142–A143. doi:10.1136/thoraxjnl-2015-207770.269
   Web of Science ®Google Scholar
• YeoJ, KarimovaG, BansalS. Co-morbidity in older patients with COPD–its impact on health service utilisation and quality of life, a community study. Age Ageing. 2006;35(1):33–37. doi:10.1093/ageing/afj00216364931
   PubMed Web of Science ®Google Scholar
• MapelDW, DutroMP, MartonJP, WoodruffK, MakeB. Identifying and characterizing COPD patients in US managed care. A retrospective, cross-sectional analysis of administrative claims data. BMC Health Serv Res. 2011;11:43. doi:10.1186/1472-6963-11-4321345188
   PubMed Web of Science ®Google Scholar
• PunekarYS, ShuklaA, MüllerovaH. COPD management costs according to the frequency of COPD exacerbations in UK primary care. Int J Chron Obstruct Pulmon Dis. 2014;9:65–73. doi:10.2147/COPD24426781
   PubMed Web of Science ®Google Scholar
• AbusaidGH, BarbagelataA, TueroE, MahmoodA, SharmaG. Diastolic dysfunction and COPD exacerbation. Postgrad Med. 2009;121(4):76–81. doi:10.3810/pgm.2009.07.203319641273
   PubMed Web of Science ®Google Scholar
• MittmannN, KuramotoL, SeungSJ, HaddonJM, Bradley-KennedyC, FitzgeraldJM. The cost of moderate and severe COPD exacerbations to the Canadian healthcare system. Respir Med. 2008;102(3):413–421. doi:10.1016/j.rmed.2007.10.01018086519
   PubMed Web of Science ®Google Scholar
• XuX, KnightT, BaikR, TuX, ParkerJM. Patient characteristics, health resource utilization (HRU) and treatment costs of chronic obstructive pulmonary disease (COPD) patients treated in hospital facilities for exacerbations. Am J Respir Crit Care Med. 2012;185:A3047.
   Google Scholar
• DalalAA, PatelJ, D’SouzaA, FarrellyE, NagarS, ShahM. Impact of COPD exacerbation frequency on costs for a managed care population. J Manag Care Spec Pharm. 2015;21(7):575–583. doi:10.18553/jmcp.2015.21.7.57526108382
   PubMed Web of Science ®Google Scholar
• PasqualeMK, SunSX, SongF, HartnettHJ, StemkowskiSA. Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly medicare population. Int J Chron Obstruct Pulmon Dis. 2012;7:757–764. doi:10.2147/COPD.S3699723152680
   PubMed Web of Science ®Google Scholar
• BlasiF, CesanaG, ContiS, et al. The clinical and economic impact of exacerbations of chronic obstructive pulmonary disease: a cohort of hospitalized patients. PLoS One. 2014;9(6):e101228. doi:10.1371/journal.pone.010122824971791
   PubMed Web of Science ®Google Scholar
• MiravitllesM, CalleM, Alvarez-GutierrezF, GobarttE, LópezF, MartinA. Exacerbations, hospital admissions and impaired health status in chronic obstructive pulmonary disease. Qual Life Res. 2006;15(3):471–480. doi:10.1007/s11136-005-3215-y16547786
   PubMed Web of Science ®Google Scholar
• VitaccaM, BianchiL, BazzaA, CliniEM. Advanced COPD patients under home mechanical ventilation and/or long term oxygen therapy: italian healthcare costs. Monaldi Arch Chest Dis. 2011;75(4):207–214. doi:10.4081/monaldi.2011.20822462308
   PubMedGoogle Scholar
• SmallM, HolbrookT, WoodR, MullerovaH, NayaI, PunekarYS. Prevalence and burden of dyspnoea among COPD patients in Japan. Int J Clin Pract. 2016;70(8):676–681. doi:10.1111/ijcp.2016.70.issue-827396989
   PubMed Web of Science ®Google Scholar
• de Miguel-díezJ, Carrasco-GarridoP, Rejas-GutierrezJ, et al. The influence of heart disease on characteristics, quality of life, use of health resources, and costs of COPD in primary care settings. BMC Cardiovasc Disord. 2010;10:8. doi:10.1186/1471-2261-10-820167091
   PubMed Web of Science ®Google Scholar
• AbudaggaA, SunSX, TanH, SolemCT. Exacerbations among chronic bronchitis patients treated with maintenance medications from a US managed care population: an administrative claims data analysis. Int J Chron Obstruct Pulmon Dis. 2013;8:175–185. doi:10.2147/COPD.S4043723589684
   PubMed Web of Science ®Google Scholar
• FooJ, LandisSH, MaskellJ, et al. Continuing to Confront COPD International Patient Survey: economic impact of COPD in 12 countries. PLoS One. 2016;11(4):e0152618. doi:10.1371/journal.pone.015261827092775
   PubMed Web of Science ®Google Scholar
• RobertsMH, BorregoM, PetersenH, KharatA, BlanchetteC. Estimating the burden and course of severe COPD exacerbations in the U.S. Hispanic population. Am J Respir Crit Care Med. 2011a;183:A1496.
   Web of Science ®Google Scholar
• SilverH, BlanchetteCM, RobertsM, PetersenH, StCharlesME. Prevalence of comorbidities in patients hospitalized for COPD exacerbations and impact on impatient mortality and hospital expenditures. Am J Respir Crit Care Med. 2010;181:A5943. doi:10.1164/rccm.200904-0493OC
   Web of Science ®Google Scholar
• Garcia-AymerichJ, Serra PonsI, ManninoDM, MaasAK, MillerDP, DavisKJ. Lung function impairment, COPD hospitalisations and subsequent mortality. Thorax. 2011;66(7):585–590. doi:10.1136/thx.2010.15287621515553
   PubMed Web of Science ®Google Scholar
• GallegoM, PomaresX, CapillaS, et al. C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severity. Int J Chron Obstruct Pulmon Dis. 2016;11:2633–2640. doi:10.2147/COPD27799762
   PubMed Web of Science ®Google Scholar
• DhamaneAD, WittEA, SuJ. Associations between COPD severity and work productivity, health-related quality of life, and health care resource use: a cross-sectional analysis of national survey data. J Occup Environ Med. 2016;58(6):e191–e197. doi:10.1097/JOM.000000000000073527206123
   PubMed Web of Science ®Google Scholar
• StanfordRH, ShenY, McLaughlinT. Cost of chronic obstructive pulmonary disease in the emergency department and hospital: an analysis of administrative data from 218 US hospitals. Treat Respir Med. 2006;5(5):343–349. doi:10.2165/00151829-200605050-0000516928147
   PubMedGoogle Scholar
• MahmudN, McNabb-BalterJ, ChanWW. The impact of gastroesophageal reflux on the length of hospital stay for COPD exacerbations: a report of the nationwide inpatient sample. Gastroenterology. 2015;148(4Suppl. 1):S606. doi:10.1016/S0016-5085(15)32044-8
   Google Scholar
• VallabhajosyulaS, HaddadTM, SundaragiriPR, et al. Role of B-type natriuretic peptide in predicting in-hospital outcomes in acute exacerbation of chronic obstructive pulmonary disease: a five-year retrospective analysis. Am J Respir Crit Care Med. 2015;191:A2938.
   Web of Science ®Google Scholar
• EscarrabillJ, TorrenteE, EsquinasC, et al. Clinical audit of patients hospitalized due to COPD exacerbation. MAG-1 Study. Arch Bronconeumol. 2015;51(10):483–489. doi:10.1016/j.arbres.2014.06.02325447590
   PubMed Web of Science ®Google Scholar
• McGhanR, RadcliffT, FishR, SutherlandER, WelshC, MakeB. Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest. 2007;132(6):1748–1755. doi:10.1378/chest.06-301817890477
   PubMed Web of Science ®Google Scholar
• ChenY, LiQ, JohansenH. Age and sex variations in hospital readmissions for COPD associated with overall and cardiac comorbidity. Int J Tuberc Lung Dis. 2009;13(3):394–399.19275803
   PubMed Web of Science ®Google Scholar
• SuissaS, Dell’AnielloS, ErnstP. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax. 2012;67(11):957–963. doi:10.1136/thoraxjnl-2011-20151822684094
   PubMed Web of Science ®Google Scholar
• QuintanaJM, EstebanC, Garcia-GutierrezS, et al. Predictors of hospital admission two months after emergency department evaluation of COPD exacerbation. Respiration. 2014;88(4):298–306. doi:10.1159/00036599625228470
   PubMed Web of Science ®Google Scholar
• NguyenHQ, ChuL, Liu I-LA, et al. Higher level of regular physical activity is associated with lower risk of 30-day readmissions in patients with COPD. Am J Respir Crit Care Med. 2014;189:A2452. doi:10.1164/rccm.201306-1150OC
   Web of Science ®Google Scholar
• GatheralT, KumarN, SansomB, et al. COPD-related bronchiectasis; independent impact on disease course and outcomes. COPD. 2014;11(6):605–614. doi:10.3109/15412555.2014.92217424983298
   PubMedGoogle Scholar
• NantsupawatT, LimsuwatC, NugentK. Factors affecting chronic obstructive pulmonary disease early rehospitalization. Chron Respir Dis. 2012;9(2):93–98. doi:10.1177/147997231243870322399574
   PubMed Web of Science ®Google Scholar
• DuVallS, BrownK, NiciL, et al. Incidence and predictors of hospital readmission among patients with chronic obstructive pulmonary disease in the Department of Veterans Affairs. Chest. 2015;148(4 Suppl):684A. doi:10.1378/chest.2223166
   Web of Science ®Google Scholar
• BenzoRP, KirschJL, DuloheryMM, Abascal-BoladoB. Emotional intelligence: a novel outcome associated with wellbeing and self-management in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2016;13(1):10–16. doi:10.1513/AnnalsATS.201508-490OC26501370
   PubMed Web of Science ®Google Scholar
• NishiSP, ZhangW, KuoYF, SharmaG. Oxygen therapy use in older adults with chronic obstructive pulmonary disease. PLoS One. 2015;10(3):e0120684. doi:10.1371/journal.pone.012068425785586
   PubMed Web of Science ®Google Scholar
• Garciía-PoloC, Alcázar-NavarreteB, Ruiz-IturriagaLA, et al. Factors associated with high healthcare resource utilisation among COPD patients. Respir Med. 2012;106(12):1734–1742. doi:10.1016/j.rmed.2012.09.00923058483
   PubMed Web of Science ®Google Scholar
• TranM, XiangP, RascatiKL, et al. HEDIS quality measure performance and other factors predictive of health care costs following COPD-related admission. Value Health. 2016;19:A122.
   Web of Science ®Google Scholar
• PunekarYS, MullerovaH, SmallM, et al. Prevalence and burden of dyspnoea among patients with chronic obstructive pulmonary disease in five European countries. Pulmonary Ther 2016;2(1):59–72.
   Google Scholar
• SrivastavaK, ThakurD, SharmaS, PunekarYS. Systematic review of humanistic and economic burden of symptomatic chronic obstructive pulmonary disease. Pharmacoeconomics. 2015;33(5):467–488. doi:10.1007/s40273-015-0252-425663178
   PubMed Web of Science ®Google Scholar
• DalalAA, ShahM, LunacsekO, HananiaNA. Clinical and economic burden of patients diagnosed with COPD with comorbid cardiovascular disease. Respir Med. 2011;105(10):1516–1522. doi:10.1016/j.rmed.2011.04.00521684731
   PubMed Web of Science ®Google Scholar
• HuberMB, WackerME, VogelmeierCF, LeidlR, WatzH. Excess costs of comorbidities in chronic obstructive pulmonary disease: a systematic review. PLoS One. 2015;10(4):e0123292. doi:10.1371/journal.pone.012329225875204
   PubMed Web of Science ®Google Scholar
• ManninoDM, HiguchiK, YuTC, et al. Economic burden of COPD in the presence of comorbidities. Chest. 2015;148(1):138–150. doi:10.1378/chest.14-243425675282
   PubMed Web of Science ®Google Scholar
• FordES, MurphyLB, KhavjouO, GilesWH, HoltJB, CroftJB. Total and state-specific medical and absenteeism costs of COPD among adults aged >/= 18 years in the United States for 2010 and projections through 2020. Chest. 2015;147(1):31–45. doi:10.1378/chest.14-097225058738
   PubMed Web of Science ®Google Scholar
• LøkkeA, UlrikCS, DahlR, et al. Detection of previously undiagnosed cases of COPD in a high-risk population identified in general practice. COPD. 2012;9(5):458–465. doi:10.3109/15412555.2012.68511822643016
   PubMedGoogle Scholar
• BuXN, YangT, ThompsonMA, HutchinsonAF, IrvingLB. Changes in the BODE index, exacerbation duration and hospitalisation in a cohort of COPD patients. Singapore Med J. 2011;52(12):894–900.22159933
   PubMed Web of Science ®Google Scholar
• Carrasco GarridoP, de Miguel DíezJ, Rejas GutiérrezJ, et al. Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study. Health Qual Life Outcomes. 2006;4:31. doi:10.1186/1477-7525-4-3116719899
   PubMed Web of Science ®Google Scholar
• CollinsEG, HalabiS, LangstonM, SchnellT, TobinMJ, LaghiF. Sexual dysfunction in men with COPD: impact on quality of life and survival. Lung. 2012;190(5):545–556. doi:10.1007/s00408-012-9398-422752718
   PubMed Web of Science ®Google Scholar
• DalalAA, ShahM, D’SouzaAO, RaneP. Costs of inpatient and emergency department care for chronic obstructive pulmonary disease in an elderly Medicare population. J Med Econ. 2010a;13(4):591–598. doi:10.3111/13696998.2010.52173420854113
   PubMedGoogle Scholar
• LindenauerPK, PekowP, GaoS, CrawfordAS, GutierrezB, BenjaminEM. Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 2006;144(12):894–903. doi:10.7326/0003-4819-144-12-200606200-0000616785478
   PubMed Web of Science ®Google Scholar
• DalalAA, ShahM, D’SouzaAO. Economic burden of health care admissions related to chronic obstructive pulmonary disease exacerbations: data from inpatient administrative database. Am J Respir Crit Care Med. 2010b;181:A1492.
   Web of Science ®Google Scholar
• PatelJ, DalalAA, NagarS, D’SouzaAO, ShahM, FarrellyE. Economic burden of frequently and infrequently exacerbating patients with a diagnosis of COPD. Am J Respir Crit Care Med. 2013;187:A1437.
   Web of Science ®Google Scholar
• DhamaneA, WittEA, HernandezG, SuJ. Association between COPD severity and work productivity, quality of life and healthcare resource use. Am J Respir Crit Care Med. 2015;191:A4447.
   Web of Science ®Google Scholar
• DushianthanA, TemblettP, BhattaA. Outcome of a cohort of older population with COPD, admitted with hypercapnaeic respiratory failure and acidosis. Am J Respir Crit Care Med. 2010;181:A1506. doi:10.1164/rccm.200904-0493OC
   Web of Science ®Google Scholar
• EstebanC, ArosteguiI, AburtoM, et al. Chronic obstructive pulmonary disease subtypes. Transitions over time. PLoS One. 2016;11(9):e0161710. doi:10.1371/journal.pone.016171027611911
   PubMed Web of Science ®Google Scholar
• GadreS, DuggalA, GuzmanJ. Epidemiological characteristics and outcomes of patients with severe COPD requiring mechanical ventilation. Chest. 2014;146(4 Suppl 2):58A. doi:10.1378/chest.199191124652410
   PubMed Web of Science ®Google Scholar
• Garcia-AymerichJ, FélezMA, EscarrabillJ, et al. Physical activity and its determinants in severe chronic obstructive pulmonary disease. Med Sci Sports Exerc. 2004;36(10):1667–1673. doi:10.1249/01.MSS.0000142378.98039.5815595285
   PubMed Web of Science ®Google Scholar
• GavazziA, De MariaR, ManzoliL, et al. Palliative needs for heart failure or chronic obstructive pulmonary disease: results of a multicenter observational registry. Int J Cardiol. 2015;184:552–558. doi:10.1016/j.ijcard.2015.03.05625767016
   PubMed Web of Science ®Google Scholar
• HuangH, LinI, GoldsteinB, RosielloR, MenzinJ. Rehospitalization rates and mortality among patients with severe chronic obstructive pulmonary disease receiving long-term oxygen therapy in a managed-care setting. Am J Respir Crit Care Med. 2014;189:A3058. doi:10.1164/rccm.201306-1150OC
   Web of Science ®Google Scholar
• KeiltyS, MurphyP, HartN. 1 year UK survival readmission rate in chronic obstructive pulmonary disease (COPD) survivors following acute non-invasive ventilation (NIV). Thorax. 2013;68(Suppl. 3):A47–A48. doi:10.1136/thoraxjnl-2013-204457.95
   Web of Science ®Google Scholar
• LusuardiM, LucioniC, De BenedettoF, MazziS, SanguinettiCM, DonnerCF. GOLD severity stratification and risk of hospitalisation for COPD exacerbations. Monaldi Arch Chest Dis. 2008;69(4):164–169. doi:10.4081/monaldi.2008.37819350838
   PubMedGoogle Scholar
• MatkovicZ, HuertaA, SolerN, et al. Predictors of adverse outcome in patients hospitalised for exacerbation of chronic obstructive pulmonary disease. Respiration. 2012;84(1):17–26. doi:10.1159/00033546722327370
   PubMed Web of Science ®Google Scholar
• PunekarYS, ShuklaA, MuellerovaH. Comparing COPD costs by exacerbation frequency and dyspnoea level in a primary care setting in the United Kingdom. Value Health. 2013;16(7):A723. doi:10.1016/j.jval.2013.08.2259
   Web of Science ®Google Scholar
• PunekarYS, WurstK, ShuklaA. COPD management costs among newly diagnosed COPD patients in the UK primary care setting. Am J Respir Crit Care Med. 2013;187:A4373.
   Web of Science ®Google Scholar
• PunekarYS, ShuklaA, MuellerovaH. Disease management costs associated with COPD patients with infrequent exacerbations in the UK primary care setting. Am J Respir Crit Care Med. 2013;187:A4374.
   Web of Science ®Google Scholar
• MerinopoulouE, Raluy-CalladoM, RamagopalanS, MacLachlanS, KhalidJM. Resource use and exacerbations of chronic obstructive pulmonary disease (COPD) by GOLD categories. Value Health. 2015;18(7):A506–A507. doi:10.1016/j.jval.2015.09.1449
   Web of Science ®Google Scholar
• FitzGeraldJM, HaddonJM, Bradley-KennedyC, KuramotoL, FordGT, RUSIC Study GroupT. The RUSIC Study Group. Resource Use Study in COPD (RUSIC): a prospective study to quantify the effects of COPD exacerbations on health care resource use among COPD patients. Can Respir J. 2007;14(3):145–152. doi:10.1155/2007/92191417464378
   PubMed Web of Science ®Google Scholar
• MolinariN, BriandC, VachierI, et al. Hospitalizations for COPD exacerbations: trends and determinants of death. COPD. 2015;12(6):621–627. doi:10.3109/15412555.2015.100793126263032
   PubMedGoogle Scholar
• PhilipJ, LoweA, GoldM, et al. Using administrative datasets to assist prognostication in chronic obstructive pulmonary disease (COPD). Palliat Med. 2010;24:S25.
   Google Scholar
• PitassiM, VitaleC, D’AmatoM, StanziolaA, MormileM, MolinoA. Impact of bronchiectasis on duration of hospitalization in patients with exacerbations of COPD. Eur Respir J. 2015;46:PA4701.
   Web of Science ®Google Scholar
• PrettoJJ, McDonaldVM, WarkPA, HensleyMJ. Multicentre audit of inpatient management of acute exacerbations of chronic obstructive pulmonary disease: comparison with clinical guidelines. Intern Med J. 2012;42(4):380–387. doi:10.1111/j.1445-5994.2011.02475.x21395962
   PubMed Web of Science ®Google Scholar
• ShortPM, WilliamsonPA, SinganayagamA, AkramA, ChalmersJD, SchembriS. Guideline adherent therapy and reduced mortality and length of stay in adults hospitalised with exacerbations of COPD. Thorax. 2013;68(Suppl. 3):A136. doi:10.1136/thoraxjnl-2013-204457.283
   Web of Science ®Google Scholar
• RobertsCM, StoneRA, LoweD, PurseyNA, BuckinghamRJ. Co-morbidities and 90-day outcomes in hospitalized COPD exacerbations. COPD. 2011b;8(5):354–361. doi:10.3109/15412555.2011.60036221864116
   PubMedGoogle Scholar
• SharafkhanehA, AltanAE, ColiceGL, et al. A simple rule to identify patients with chronic obstructive pulmonary disease who may need treatment reevaluation. Respir Med. 2014;108(9):1310–1320. doi:10.1016/j.rmed.2014.07.00225130680
   PubMed Web of Science ®Google Scholar
• SteerJ, GibsonGJ, BourkeSC. Longitudinal change in quality of life following hospitalisation for acute exacerbations of COPD. BMJ Open Respir Res. 2015;2(1):e000069. doi:10.1136/bmjresp-2014-000069
   PubMed Web of Science ®Google Scholar
• StefanMS, NathansonB, LindenauerP, HigginsT, SteingrubJ. Characteristics, ventilation strategies, and outcomes of patients hospitalized in intensive care units with an acute exacerbation of COPD. Am J Respir Crit Care Med. 2014;189:A1632. doi:10.1164/rccm.201306-1150OC
   Web of Science ®Google Scholar
• StefanMS, ShiehMS, PekowPS, HillN, RothbergMB, LindenauerPK. Trends in mechanical ventilation among patients hospitalized with acute exacerbations of COPD in the United States, 2001 to 2011. Chest. 2015;147(4):959–968. doi:10.1378/chest.14-121625375230
   PubMed Web of Science ®Google Scholar
• ThomasM, RadwanA, StonhamC, MarshallS. Exacerbation frequency and maintenance treatment of COPD in UK clinical practice. Thorax. 2011;66(Suppl 4):A153. doi:10.1136/thoraxjnl-2011-201054c.211
   Web of Science ®Google Scholar
• VitaccaM, EscarrabillJ, GalavottiG, et al. Home mechanical ventilation patients: a retrospective survey to identify level of burden in real life. Monaldi Arch Chest Dis. 2007;67(3):142–147. doi:10.4081/monaldi.2007.48518018753
   PubMedGoogle Scholar
• WangQ, BourbeauJ. Outcomes and health-related quality of life following hospitalization for an acute exacerbation of COPD. Respirology. 2005;10(3):334–340. doi:10.1111/res.2005.10.issue-315955146
   PubMed Web of Science ®Google Scholar
• YuAP, YangH, WuEQ, SetyawanJ, MocarskiM, BlumS. Incremental third-party costs associated with COPD exacerbations: a retrospective claims analysis. J Med Econ. 2011;14(3):315–323. doi:10.3111/13696998.2011.57629521500975
   PubMedGoogle Scholar